The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity

被引:134
|
作者
Greenwald, J
Le, V
Butler, SL
Bushman, FD
Choe, S
机构
[1] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA
[2] Salk Inst Biol Studies, Infect Dis Lab, La Jolla, CA 92037 USA
[3] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92037 USA
关键词
D O I
10.1021/bi9907173
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Replication of HIV-1 requires the covalent integration of the viral cDNA into the host chromosomal DNA directed by the virus-encoded integrase protein. Here we explore the importance of a protein surface loop near the integrase active site using protein engineering and X-ray crystallography. We have redetermined the structure of the integrase catalytic domain (residues 50-212) using an independent phase set at 1.7 Angstrom resolution. The structure extends helix alpha 4 on its N-terminal side (residues 149-154), thus defining the position of the three conserved active site residues. Evident in this and in previous structures is a conformationally flexible loop composed of residues 141-148. To probe the role of flexibility in this loop, we replaced Gly 140 and Gly 149, residues that appear to act as conformational hinges, with Ala residues. X-ray structures of the catalytic domain mutants G149A and G140A/G149A show further rigidity of alpha 4 and the adjoining loop. Activity assays in vitro revealed that these mutants are impaired in catalysis. The DNA binding affinity, however, is minimally affected by these mutants as assayed by UV cross-linking. We propose that the conformational flexibility of this active site loop: is important for a postbinding catalytic step.
引用
收藏
页码:8892 / 8898
页数:7
相关论文
共 50 条
  • [31] BIOPHYSICAL AND ENZYMATIC-PROPERTIES OF THE CATALYTIC DOMAIN OF HIV-1 INTEGRASE
    HICKMAN, AB
    PALMER, I
    ENGELMAN, A
    CRAIGIE, R
    WINGFIELD, P
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (46) : 29279 - 29287
  • [32] Brownian and essential dynamics studies of the HIV-1 integrase catalytic domain
    Weber, W
    Demirdjian, H
    Lins, RD
    Briggs, JM
    Ferreira, R
    McCammon, JA
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 1998, 16 (03): : 733 - 745
  • [33] Symmetrical 1-pyrrolidineacetamide showing anti-HIV activity through a new binding site on HIV-1 integrase
    Li Du
    Ya-xue Zhao
    Liu-meng Yang
    Yong-tang Zheng
    Yun Tang
    Xu Shen
    Hua-liang Jiang
    Acta Pharmacologica Sinica, 2008, 29 : 1261 - 1267
  • [34] Symmetrical 1-pyrrolidineacetamide showing anti-HIV activity through a new binding site on HIV-1 integrase
    Du, Li
    Zhao, Ya-xue
    Yang, Liu-meng
    Zheng, Yong-tang
    Tang, Yun
    Shen, Xu
    Jiang, Hua-liang
    ACTA PHARMACOLOGICA SINICA, 2008, 29 (10) : 1261 - 1267
  • [35] LEDGINs, non-catalytic site inhibitors of HIV-1 integrase: a patent review (2006-2014)
    Demeulemeester, Jonas
    Chaltin, Patrick
    Marchand, Arnaud
    De Maeyer, Marc
    Debyser, Zeger
    Christ, Frauke
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2014, 24 (06) : 609 - 632
  • [36] Understanding the integrase inhibitory activity of azido containing HIV-1 integrase inhibitors.
    Karki, RG
    Nicklaus, MC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U7 - U7
  • [37] Synthesis and HIV-1 Integrase Inhibitory Activity of Furanone Derivatives
    Yu Sheng-hui
    Zhao Si-tai
    Liu Chuan
    Zhong Yuan
    Zhao Gui-sen
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2010, 26 (02) : 225 - 229
  • [39] Studies of HIV-1 Integrase Inhibitory Activity of Wrightia tinctoria
    Selvam, Periyasamy
    Maddali, Kasthuraiah
    Pommier, Yves
    ANTIVIRAL RESEARCH, 2010, 86 (01) : A28 - A28
  • [40] Modified Cyclic Peptides as Inhibitors of HIV-1 Integrase Activity
    Northfield, E.
    Headey, S.
    Scanlon, M.
    Thompson, P.
    Chalmers, D.
    JOURNAL OF PEPTIDE SCIENCE, 2010, 16 : 130 - 130